Erratum: Identifying patients with suspected lung cancer in primary care: Derivation and validation of an algorithm (Br J Gen Pract (2011) DOI: 10.3399/bjgp11X606627);Identifying patients with suspected lung cancer in primary care: Derivation and validation of an algorithm

British Journal of General Practice

Volumn 61, Issue 592, 2011, Pages 64-

  Hippisley Cox, Julia ^a   Coupland, Carol ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Diagnosis; Lung cancer; Primary care; Qresearch; Risk prediction; Symptoms

Indexed keywords

ADULT; ALGORITHM; ANEMIA; ANOREXIA; ARTICLE; ASBESTOSIS; ASTHMA; BODY MASS; CANCER INCIDENCE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DEPRIVATION SCORE; DYSPNEA; FAMILY HISTORY; FATIGUE; FEMALE; HEMOPTYSIS; HOARSENESS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PNEUMONIA; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; SCORING SYSTEM; SMOKING; WEIGHT REDUCTION;

EID: 83355174129     PISSN: 09601643     EISSN: 14785242     Source Type: Journal    
DOI: 10.3399/bjgp15X683473     Document Type: Erratum

References (38)

1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18(3): 581-592. (Pubitemid 46359643)
2. The Information Centre. National Lung Cancer Audit. Key findings about the quality of care for people with lung cancer in England incorporating headline and completeness data from Wales. Report for the audit period 2006. Leeds: The Information Centre, 2006. http://www.ic.nhs.uk/webfiles/Services/ NCASP/Cancer/Lung%20cancer%202006.pdf (accessed 13 Jul 2011).
3. van Rens MTM, Brutel de la Rivière AB, Elbers HRJ, van den Bosch JMM. Prognostic assessment of 2361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000; 117(2): 374-379.
4. Field JK, Raji OY. The potential for using risk models in future lung cancer screening trials. F1000 Med Rep 2010; 2. pii: 38.
5. Silvestri GA, Alberg AJ, Ravenel J. The changing epidemiology of lung cancer with a focus on screening. BMJ 2009; 339: b3053.
6. US National Cancer Institute. Lung cancer trial results show mortality benefit with low-dose CT. Bethseda: US National Cancer Institute, 2010.
7. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321(7257): 323-329. (Pubitemid 30496873)
8. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2007; 98(2): 270-276.
9. Crispo A, Brennan P, Jockel KH, et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 2004; 91(7): 1280-1286. (Pubitemid 39424788)
10. Subramanian J, Govindan R. Lung cancer in never smokers. J Clin Oncol 2007; 25(5): 9.
11. Lubin JH, Alavanja MCR, Caporaso N, et al. Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol 2007; 166(4): 479-489. (Pubitemid 47216789)
12. Hamilton W, Peters TJ, Round A, Sharp D. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 2005; 60(12): 1059-1065. (Pubitemid 41705477)
13. Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007; 334(7602): 1040.
14. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007; 99(9): 715-726. (Pubitemid 47073532)
15. Spitz MR, Etzel CJ, Dong Q, et al. Expanded risk prediction model for lung cancer. Cancer Prev Res 2008; 1(4): 250-254.
16. Hippisley-Cox J, Coupland C, Robson J, et al. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009; 338: b880.
17. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009; 339: b4229.
18. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336(7659): 1475-1482. (Pubitemid 351977019)
19. Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney® scores. BMC Fam Pract 2010; 11: 49.
20. Hippisley-Cox J, Coupland C. Individualising the risks of statins in men and women in England and Wales: population based cohort study. Heart 2010; 96(1): 939-947.
21. Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ 2009; 339: b3094.
22. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003; 95(6): 470-478. (Pubitemid 36432421)
23. National Cancer Intelligence Network. Cancer incidence by deprivation in England, 1995-2004. London: National Cancer Intelligence Network, 2008.
24. De Vos Irvine H, Lamont DW, et al. Asbestos and lung cancer in Glasgow and the west of Scotland. BMJ 1993; 306(6891): 1503-1506. (Pubitemid 23159632)
25. Royston P. Multiple imputation ofmissing values. Stata J 2004; 4(3): 227-241.
26. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28(5): 964-974. (Pubitemid 29525041)
27. Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 2010; 341: c6624.
28. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004; 23(5): 723-748. (Pubitemid 38279510)
29. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17(8): 857-872. (Pubitemid 28185165)
30. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. London: National Institue for Health and Clinical Excellence, 2005.
31. Cancer Research UK. Lung Cancer - UK incidence statistics. London: Cancer Research UK, 2010.
32. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302(6779): 766-768.
33. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69(1): 4-14.
34. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60(572): e128-136.
35. Jick H, Jick S, Derby LE, et al. Calcium-channel blockers and risk of cancer. Lancet 1997; 349(9066): 525-528. (Pubitemid 27092790)
36. Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer 2009; 101(Suppl 2): S80-86.
37. Kabat GC. Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers. Cancer Causes Control 1993; 4(5): 489-495. (Pubitemid 23290764)
38. Mery CM, Pappas AN, Bueno R, et al. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest 2004; 125(6): 2175-2181. (Pubitemid 38788187)